Atlas Trials

Patients With Persistent Objectified Gastroesophageal Reflux and Reflux-Associated Symptoms Despite PPI-Therapy With 40mg Esomeprazole

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Patients With Persistent Objectified Gastroesophageal Reflux and Reflux-Associated Symptoms Despite PPI-Therapy With 40mg Esomeprazole

RecordFirmDate
High Dosage Esomeprazole and Baclofen for Therapy of Gastroesophageal Reflux Disease (NCT00461604)Technical University of Munich2006-10-01

Track Patients With Persistent Objectified Gastroesophageal Reflux and Reflux-Associated Symptoms Despite PPI-Therapy With 40mg Esomeprazole automatically

Every clearance here is in the API, with alerts when new ones post.